Tag: (ASX:CSL)
Paul McKenzie to take reins as CSL’s new CEO, managing director
Global biotechnology giant CSL Limited has named Paul McKenzie as its chief executive officer and managing director, effective 6 March 2023.
CSL makes record 45% profit leap, takes on vaccine manufacturing
As demand for vaccines ramps up, the blood products giant has taken on the enormous task of manufacturing COVID-19 jabs – and so far,...
Featured Article
AI-powered energy savings: A guide for Aussie SMEs
As the world grapples with the challenges of climate change, Australian manufacturers are increasingly recognising the need to reduce their carbon footprint and transition towards a more sustainable future.
